These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16369067)

  • 1. [Functional status of haemostasis system in patients with visceral leishmaniasis].
    Lomtadze ML; Khochava MA; Shalamberidze IA; Shilakadze MA; Dzhokhtaberidze TG
    Georgian Med News; 2005 Nov; (128):59-62. PubMed ID: 16369067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of intravascular coagulation activation markers in patients with visceral leishmaniasis].
    Lomtadze ML; Khochava MA; Shalamberidze IA; Kharaishvili VI; Vorob'eva EO
    Georgian Med News; 2005; (124-125):47-50. PubMed ID: 16148377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of haemostatic disorders in experimentally induced leishmaniasis in Beagle dogs.
    Valladares JE; Ruiz De Gopegui R; Riera C; Alberola J; Gállego M; Espada Y; Portús M; Arboix M
    Res Vet Sci; 1998; 64(3):195-8. PubMed ID: 9690602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
    Aste G; Di Tommaso M; Steiner JM; Williams DA; Boari A
    Vet Res Commun; 2005 Aug; 29 Suppl 2():269-72. PubMed ID: 16244972
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences.
    Juzlova K; Votrubova J; Kacerovska D; Lukas M; Bortlik M; Rohacova H; Nohynkova E; Vojackova N; Fialova J; Hercogova J
    Dermatol Ther; 2014; 27(3):131-4. PubMed ID: 24903470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M; Brunet P; Bernard JC; Dussol B; Rodor F; Jouglard J; Berland Y; Sahel J
    Gastroenterol Clin Biol; 1994; 18(1):90-2. PubMed ID: 8187998
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
    Oliveira AL; Brustoloni YM; Fernandes TD; Dorval ME; Cunha RV; Bóia MN
    Trop Doct; 2009 Jul; 39(3):180-2. PubMed ID: 19535762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exploration of hemostasis in current practice].
    Aiach M; Gaussem P
    Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential causes of epistaxis in dogs with natural visceral leishmaniasis.
    Jüttner C; Rodríguez Sánchez M; Rollán Landeras E; Slappendel RJ; Fragío Arnold C
    Vet Rec; 2001 Aug; 149(6):176-9. PubMed ID: 11530902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side effects of treatment with antimony salts.
    Malta R; Affronti M; Di Rosa S; Vassallo L; Renda M; Trifirò G; Rubino ME; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):628-9. PubMed ID: 16312564
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the cardiac toxicity of N-methyl-glucamine antimoniate in dogs with naturally occurring leishmaniasis.
    Luciani A; Sconza S; Civitella C; Guglielmini C
    Vet J; 2013 Apr; 196(1):119-21. PubMed ID: 23021954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 20. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.